Tania Rossi

460 total citations
25 papers, 322 citations indexed

About

Tania Rossi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tania Rossi has authored 25 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Tania Rossi's work include Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (8 papers) and Extracellular vesicles in disease (4 papers). Tania Rossi is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (8 papers) and Extracellular vesicles in disease (4 papers). Tania Rossi collaborates with scholars based in Italy, China and United States. Tania Rossi's co-authors include Francesca Fanini, Francesca Pirini, Daniele Vergara, Michele Maffia, Sara Bravaccini, Francesco� Fabbri, Giulia Gallerani, Roberta Maltoni, Giovanni Martinelli and Paola Ulivi and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Tania Rossi

21 papers receiving 321 citations

Peers

Tania Rossi
Dennis Poel Netherlands
Tania Rossi
Citations per year, relative to Tania Rossi Tania Rossi (= 1×) peers Dennis Poel

Countries citing papers authored by Tania Rossi

Since Specialization
Citations

This map shows the geographic impact of Tania Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Rossi more than expected).

Fields of papers citing papers by Tania Rossi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Rossi. The network helps show where Tania Rossi may publish in the future.

Co-authorship network of co-authors of Tania Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Rossi. A scholar is included among the top collaborators of Tania Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Rossi. Tania Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossi, Tania, Emanuela Scarpi, & Roberta Maltoni. (2025). Circulating Tumor Cells in Early Breast Cancer: A 10-Year Follow-Up Update. Biomedicines. 13(6). 1278–1278.
2.
Rossi, Tania, Martina Valgiusti, Maurizio Puccetti, et al.. (2025). Gastroesophageal circulating tumor cell crosstalk with peripheral immune system guides CTC survival and proliferation. Cell Death and Disease. 16(1). 223–223.
3.
Masciale, Valentina, Federico Banchelli, Giulia Grisendi, et al.. (2024). The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations. Journal of Biological Chemistry. 300(12). 107994–107994. 2 indexed citations
4.
Gerratana, Lorenzo, Andrew A. Davis, Carolina Reduzzi, et al.. (2024). Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling. Cancer Letters. 609. 217325–217325. 13 indexed citations
5.
Zanoni, Michele, Tania Rossi, Martina Valgiusti, et al.. (2024). Abstract 7610: Predictive biomarkers for immuno-chemotherapy response in biliary tract malignancies. Cancer Research. 84(6_Supplement). 7610–7610.
6.
Zampiga, Valentina, Ilaria Cangini, Valentina Arcangeli, et al.. (2023). A Novel FLCN Variant in a Suspected Birt–Hogg–Dubè Syndrome Patient. International Journal of Molecular Sciences. 24(15). 12418–12418.
7.
Vannini, Ivan, Tania Rossi, Martina Valgiusti, et al.. (2023). Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value. Molecular Therapy — Methods & Clinical Development. 29. 473–482. 8 indexed citations
8.
Andrikou, Kalliopi, Tania Rossi, Alberto Verlicchi, et al.. (2023). Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 24(22). 16085–16085. 14 indexed citations
9.
Gallerani, Giulia, Tania Rossi, Manuela Ferracin, & Massimiliano Bonafè. (2023). Settling the uncertainty about unconventional circulating tumor cells: Epithelial-to-mesenchymal transition, cell fusion and trogocytosis. International review of cell and molecular biology. 381. 99–111. 7 indexed citations
11.
Maltoni, Roberta, Tania Rossi, Francesco� Fabbri, et al.. (2022). Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study. Current Oncology. 29(2). 433–438. 1 indexed citations
12.
Rossi, Tania, et al.. (2022). From phenotypical investigation to RNA-sequencing for gene expression analysis: A workflow for single and pooled rare cells. Frontiers in Genetics. 13. 1012191–1012191. 2 indexed citations
13.
Vannini, Ivan, Milena Urbini, Tania Rossi, et al.. (2022). Case Report: Analysis of Plasma Extracellular Vesicles in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Frontiers in Medicine. 9. 827206–827206. 1 indexed citations
14.
Rossi, Tania, Giulia Gallerani, Giovanni Martinelli, Roberta Maltoni, & Francesco� Fabbri. (2021). Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines. 9(9). 1242–1242. 12 indexed citations
15.
Rossi, Tania, et al.. (2021). Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?. Frontiers in Medicine. 8. 725346–725346. 7 indexed citations
16.
Rossi, Tania, Emanuela Scarpi, Giulia Gallerani, et al.. (2021). Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer. Frontiers in Molecular Biosciences. 8. 732900–732900. 11 indexed citations
17.
Rossi, Tania, Michela Palleschi, Michela Tebaldi, et al.. (2021). Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Frontiers in Medicine. 8. 689895–689895. 4 indexed citations
18.
Rossi, Tania, Daniele Vergara, Francesca Fanini, et al.. (2020). Microbiota-Derived Metabolites in Tumor Progression and Metastasis. International Journal of Molecular Sciences. 21(16). 5786–5786. 110 indexed citations
19.
Fanini, Francesca, Ivan Vannini, Tania Rossi, et al.. (2020). miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines. Frontiers in Cell and Developmental Biology. 8. 579160–579160. 17 indexed citations
20.
Matteis, Serena De, Chiara Molinari, Tania Rossi, et al.. (2018). Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients. Journal of Translational Medicine. 16(1). 172–172. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026